D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 41,200
+350 (0.86%)
Nov 2, 2026, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 1.89 trillion as of October 30, 2026. It is the 8,178th most valuable company in the world and the 202nd biggest in South Korea. Its market cap has decreased by 37.43% in one year.
Market Cap
1.89T
Enterprise Value
1.85T
Revenue
2.75B
Global Rank
Country Rank
#202 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 1.89T, an increase of 397.55%. That is a compound annual growth rate of 89.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 1.89T | -52.75% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HLB Co., Ltd. | 5.32T |
| SK bioscience | 2.56T |
| LigaChem Biosciences | 2.27T |
| ABL Bio | 2.19T |
| Peptron | 2.15T |
| OliX Pharmaceuticals | 2.14T |
| Hugel | 1.94T |
| Voronoi | 1.92T |